Families of children harmed by a drug that caused up to 20,000 babies to be born with disabilities have welcomed calls for compensation after their plight was compared to the thalidomide scandal. The ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has revised its guidance on sodium valproate use in men, removing a requirement for dual specialist reviews for those already on the ...

Maternal use of valproate during pregnancy has been associated with an increased risk of neurodevelopmental disorders in children. Although most studies of other antiseizure medications have not shown ...

The Department for Work and Pensions (DWP) has issued an important update regarding Personal Independence Payment (PIP) assessments, shedding light on the handling of disabilities caused by the use of ...